07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

to lectin mitogens occur in a variety of primary and secondary immunodeficiency diseases including<br />

diseases that affect T lymphocytes, B lymphocytes, and T and B lymphocytes.(2) Specific antigen<br />

recognition involves T-cell receptor recognition of specific peptide in the context of the appropriate MHC<br />

molecule on an antigen-presenting cell. T cells activate and proliferate in response to specific antigenic<br />

stimulus. The recall antigens (eg, Candida albicans and tetanus toxoid) are used to assess antigen-specific<br />

T-cell responses. The absolute counts of lymphocyte subsets are known to be influenced by a variety of<br />

biological factors, including hormones, the environment, and temperature. The studies on diurnal<br />

(circadian) variation in lymphocyte counts have demonstrated progressive increase in CD4 T-cell count<br />

throughout the day, while CD8 T cells and CD19+ B cells increase between 8:30 a.m. and noon, with no<br />

change between noon and afternoon. Natural killer (NK) cell counts, on the other hand, are constant<br />

throughout the day.(3) Circadian variations in circulating T-cell counts have been shown to be negatively<br />

correlated with plasma cortisol concentration.(4-6) In fact, cortisol and catecholamine concentrations<br />

control distribution and, therefore, numbers of naive versus effector CD4 and CD8 T cells.(4) It is<br />

generally accepted that lower CD4 T-cell counts are seen in the morning compared with the evening (7),<br />

and during summer compared to winter.(8) These data, therefore, indicate that timing and consistency in<br />

timing of blood collection is critical when serially monitoring patients for lymphocyte subsets.<br />

Useful For: Evaluating patients suspected of having diminished cellular immune function Evaluating<br />

patients with primary and secondary immunodeficiency diseases that affect T lymphocytes, including<br />

combined immunodeficiency diseases (eg, severe combined immunodeficiency, cellular<br />

immunodeficiency diseases, and some patients with humoral immunodeficiency diseases (eg, common<br />

variable immunodeficiency) Evaluating functional T-cell recovery post-hematopoietic stem cell<br />

transplant or immunosuppressive therapy for solid-organ transplantation or in other clinical contexts<br />

Interpretation: Diminished responses to lectin mitogens and/or antigens may be consistent with a<br />

primary or secondary immunodeficiency disease. Abnormal results are not specific for a particular<br />

disease, and the magnitude of the abnormality is not necessarily related to the degree of<br />

immunodeficiency. In the case of antigen-specific proliferative responses, it is possible to have low or<br />

absent responses if a long interval has passed since the original or booster vaccination (tetanus toxoid).<br />

Reference Values:<br />

LYMPHOCYTE PROLIFERATION TO ANTIGENS<br />

Viability of lymphocytes at day 0: > or =75.0%<br />

Maximum proliferation of Candida albicans as % CD45: > or =5.7%<br />

Maximum proliferation of Candida albicans as % CD3: > or =3.0%<br />

Maximum proliferation of tetanus toxoid as % CD45: > or =5.2%<br />

Maximum proliferation of tetanus toxoid as % CD3: > or =3.3%<br />

LYMPHOCYTE PROLIFERATION TO MITOGENS<br />

Viability of lymphocytes at day 0: > or =75.0%<br />

Maximum proliferation of phytohemagglutinin as % CD45: > or =49.9%<br />

Maximum proliferation of phytohemagglutinin as % CD3: > or =58.5%<br />

Maximum proliferation of pokeweed mitogen as % CD45: > or =4.5%<br />

Maximum proliferation of pokeweed mitogen as % CD3: > or =3.5%<br />

Maximum proliferation of pokeweed mitogen as % CD19: > or =3.9%<br />

Clinical References: 1. Fletcher MA, Urban RG, Asthana D, et al: Lymphocyte proliferation. In<br />

Manual of Clinical Laboratory Immunology. 5th edition. Edited by NR Rose, EC de Macario, JD Folds,<br />

et al. Washington DC. ASM Press, 1997, pp 313-319 2. Bonilla FA, Bernstein IL, Khan DA, et al:<br />

Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy<br />

Asthma Immunol 2005;94:S1-S63 3. Carmichael KF, Abayomi A: Analysis of diurnal variation of<br />

lymphocyte subsets in healthy subjects and its implication in HIV monitoring and treatment. 15th Intl<br />

Conference on AIDS, Bangkok, Thailand, 2004, Abstract B11052 4. Dimitrov S, Benedict C, Heutling<br />

D, et al: Cortisol and epinephrine control opposing circadian rhythms in T-cell subsets. Blood<br />

2009;113:5134-5143 5. Dimitrov S, Lange T, Nohroudi K, Born J: Number and function of circulating<br />

antigen presenting cells regulated by sleep. Sleep 2007;30:401-411 6. Kronfol Z, Nair M, Zhang Q, et<br />

al: Circadian immune measures in healthy volunteers: relationship to hypothalamic-pituitary-adrenal<br />

axis hormones and sympathetic neurotransmitters. Psychosom Med 1997;59:42-50 7. Malone JL,<br />

Simms TE, Gray GC, et al: Sources of variability in repeated T-helper lymphocyte counts from HIV<br />

Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong>Laboratories.com Page 1139

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!